AMPH

Amphastar Pharm

Vol:

Amphastar Pharm (AMPH)

Previous Close
$40.01

- 1.36
- 3.52%

Volume:
410,100

Volume % Chg:
- 6%

Get a Leaderboard Chart for AMPH

?

See How IBD Rates
AMPH

Daily Weekly

Amphastar Pharm (AMPH) - Develops, manufactures generic and proprietary injectable, inhalation, and intranasal products

GROUP LEADERSHIP

Medical-Biomed/Biotech Group

AMPH

is ranked

#60

60^th in group

ALPN

is ranked

1^st in group

More analysis for ALPN:

IBD RATINGS FOR AMPH

Checklist
Rating

Composite Rating
?

EPS Rating
99

RS Rating
?

Group RS Rating
?

SMR Rating
A

Acc/Dis Rating
?

Take a Free Trial to see all ratings

AMPH NEWS

AMPH NEWS FROM IBD
AMPH NEWS - IBD PARTNERS

IBD

Agios Pharmaceuticals Stock Earns IBD Stock Upgrade Again, Hitting 90-Plus RS Rating

Agios Pharmaceuticals (AGIO) stock had its Relative Strength (RS) Rating upgraded from 84 to 91 Monday. When looking for the ...

Investor's Business Daily 02/26/2024 03:12 PM ET

Amphastar Pharm Getting Closer To Key Technical Measure

On Monday, Amphastar Pharm (AMPH) earned an upgrade to its Relative Strength (RS) Rating, from 70 to 75. When looking ...

Investor's Business Daily 02/26/2024 03:00 AM ET

It May Be Time To Revisit Amphastar Once It Settles After A Plunge

Drug stock Amphastar Pharmaceuticals (AMPH) has formed a cup base and settled down after a steep sell-off in January. Now, ...

Investor's Business Daily 02/16/2024 08:00 AM ET

Amazon Stock, AppFolio, CleanSpark Among 16 Stocks Flagged By IBD's Quality Screens

IBD stock screens are regularly updated to add new stocks to watch, as well as weed out those that have ...

Investor's Business Daily 02/12/2024 06:12 PM ET

Cassava Sciences Stock Continues Showing Rising Relative Strength

On Tuesday, Cassava Sciences (SAVA) reached an important technical milestone, seeing its Relative Strength (RS) Rating jump into the 90-plus ...

Investor's Business Daily 01/16/2024 11:25 AM ET

View All »

IBD Partners

No News Available.

STOCK/COMPANY DATA FOR AMPH

Stock Data

Today's Range
38.48 - 40.06

52-Week Range
35.62 - 67.66

Price % Chg. YTD
-35.31%

Price % Chg. Last 4 Weeks
-8.88%

50-Day Avg. Volume
436,900

Shares Outstanding
48.1 Mil

Float
34.1 Mil

IPO Date
06/25/2014

Investment Bank
Jefferies Llc

% Mgmt Owns
28.4%

PE Ratio
12

Dividend Yield
0

Alpha
-0.06

Beta
0.79

Company Fundamentals

EPS Due Date
5/9/2024

EPS % Chg (Last Qtr)
21%

3 Year EPS Growth Rate
70%

EPS Est % Chg (Current Yr)
9%

Annual ROE
30.1%

Sales % Chg (Last Qtr)
32%

3-Year Sales Growth Rate
21%

Debt %
92%

Market Cap
$1.9 B $2 Bil

Annual Pre -Tax Margin
34.2%

Sector
medical

Industry Group
Medical-Biomed/Biotech

Industry Group Rank
20